The Prevalence of Helicobacter pylori Infection in Patients with Chronic Kidney Disease Undergoing Hemodialysis
By:
References
- Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: A review. JAMA 2019; 322(13):1294–304.
- Neuen BL, Chadban SJ, Demaio AR, Johnson DW, Perkovic V. Chronic kidney disease and the global NCDs agenda. BMJ Glob Health. 2017; 2(2): e000380.
- GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020; 395: 709–33.
- Bello AK, Alrukhaimi M, Ashuntantang GE, Basnet S, Rotter RC, Douthat WG, et al. Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. Kidney Int Suppl 2017; 7(2): 122–9.
- Kızıltaş Ş, Şahin S. Upper gastrointestinal disorders among dialysis patients. ACU Sağlık Bil Derg 2019; 10(2):135–41.
- Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada J-R, et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130(5): 1466–79.
- Ariffin NFM, Naing L, Pisharam J, Khalil MAM, Tamin N, Chong VH, et al. Appetite and gastrointestinal symptoms in end stage renal disease patients. J Clin Exp Nephrol 2016; 1(2): 1–6.
- Lisowska-Myjak B: Uremic toxins and their effects on multiple organ systems. Nephron Clin Pract 2014; 128: 303–11.
- Broberg B, Madsen JL, Fuglsang S, Holst JJ, Christensen KB, Rydahl C, et al. Gastrointestinal motility in patients with end-stage renal disease on chronic hemodialysis. Neurogastroenterol Motil 2019; 31(4): e13554.
- Scarpioni R, Ricardi M, Albertazzi V, De Amicis S, Rastelli F, and Zerbini L. Dialysis-related amyloidosis: challenges and solutions. Int J Nephrol Renovasc Dis. 2016; 9: 319–28.
- Turshudzhyan A, Inyangetor D. Uremic and post-transplant gastropathy in patients with chronic kidney disease and end-stage renal disease. Cureus 2020; 21; 12(9): e10578.
- Sugimoto M, Yasuda H, Andoh A. Nutrition status and Helicobacter pylori infection in patients receiving hemodialysis. World J Gastroenterol 2018; 24(15): 1591–600.
- Khedmat H, Ahmadzad-Asl M, Amini M, Lessan-Pezeshki M, Einollahi B, Pourfarziani V, et al. Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients. Transplant Proc 2007; 39(4): 1003–7.
- Ji Yong Ahn. Prevalence of Helicobacter pylori infection in patients with chronic kidney disease. Gut Liver 2019; 13(6): 585–6.
- Abdulrahman IS, Al-Mueilo SH, Ismail MH, Yasawy MI, Al-Qahtani FN, Al-Qorain AA. Does helicobacter pylori infection in chronic renal failure increase the risk of gastroduodenal lesions? A prospective study. Saudi J gastroenterol 2004; 10(2): 78–85.
- Usta M, Ersoy A, Ayar Y, Ocakoğlu G, Yuzbasioglu B, Erdem ED, Erdogan O. Comparison of endoscopic and pathological findings of the upper gastrointestinal tract in transplant candidate patients undergoing hemodialysis or peritoneal dialysis treatment: a review of literature. BMC Nephrol 2020; 21:444–52.
- Ponticelli C, Passerini P. Gastrointestinal complications in renal transplant recipients. Transpl Int 2005;18: 643–50.
- Santos PR, Monteiro DL, de Paula PH, Neto VL, Monte Coelho ML, Arcanjo CC, et al. Volaemic status and dyspepsia in end-stage renal disease patients. Nephrology (Carlton) 2015; 20: 519–22.
- Drossman DA, Dumitrascu DL. Rome III: New standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis 2006; 15(3): 237–41.
- Sugimoto M, Sakai K, Kita M, Imanishi J, Yamaoka Y. Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int 2009; 75: 96–103.
- Chang WC, Jo Y-I, Park H-S, Jegal J, Park J-H, Lee J-H, et al. Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patient. Clin Exp Nephrol 2010; 14: 469–73.
- Kaneko H, Konagaya T, Kusugami K. Helicobacter pylori and gut hormones. J Gastroenterol 2002; 37(2): 77–86.
- Junior, LDS, Santos PR, dos Santos AA, Henrique M, de Souza LP. Dyspepsia and gastric emptying in end-stage renal disease patients on hemodialysis. BMC Nephrol 2013; 14: 275.
- Huang Y, Wang Q, Cheng D, Xu W, and Lu N. Adhesion and invasion of gastric mucosa epithelial cells by Helicobacter pylori. Front Cell Infect Microbiol 2016; 6:159.
- Aydemir S, Ozdemir BH, Gurg G, Dogan I, Yilmaz U, Boyacioglu S. Effects of Helicobacter pylori infection on gastric epithelial cell kinetics in patients with chronic renal failure. World J Gastroenterol 2005; 11(45): 7183–7.
- Wijarnpreecha K, Thongprayoon C, Nissaisorakarn P, Lekuthai N, Jaruvongvanich V, Nakkala K, et al. Association betwwen Helicobacter pylori and end-stage renal disease: A meta-analysis. World J Gastroenterol 2017; 23(8): 1497–506.
- Nakajima F, Sakaguchi M, Oka H, Kawase Y, Shibahara N, Inoue T, et al. Prevalence of Helicobacter pylori antibodies in long-term dialysis patients. Nephrology (Carlton) 2004; 9: 73–6.
- Karn W, Charat T, Pichaphon N, et al. Association of Helicobacetr pylori with chronic kidney diseases: a meta-analysis. 2017 Springer, Berlin.
- Li KJ, Chen L. Association between duration of dialysis and Helicobacter pylori infection in dialysis patients: a meta-analysis. Int Urol Nephrol 2019; 51(8): 1361–70.
- Nakajima F, Sakaguchi M, Amemoto K, Oka H, Kubo M, Shibahara N, et al. Helicobacter pylori in patients receiving long-term dialysis. Am J Nephrol 2002; 22: 468–72.
- Rasmi Y, Farshid S, Makhdomi K. Effect of duration on hemodialysis on prevalence of Helicobacter pylori infection. Saudi J Kidney Dis Transplant 2012; 23: 489–92.
- Itatsu T, Miwa H, Nagahara A, Kubota M, Miyazaki A, Sato N, Hayashida Y. Eradication of Helicobacter pylori in hemodialysis patients. Renal Failure 2007; 29: 97–102.
- Watanabe H, Hiraishi H, Ishida M, Kazama J, Terano A. Pathophysiology of gastric acid secretion in patients with chronic renal failure: influence of Helicobacter pylori infection. J Intern Med 2003; 254(5): 439–46.
- Sahara S, Sugimoto M, Ichikawa H, Kagami T, Sakao Y, Ohashi N, et al. Efficacy of reduced dosage of amoxicillin in an eradication therapy for Helicobacter pylori infection in patients on hemodialysis: A randomized controlled trial. Digestion 2018; 97(2): 163–9.
Language: English
Page range: 225 - 232
Submitted on: Aug 2, 2021
Accepted on: Sep 28, 2021
Published on: Mar 22, 2022
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2022 Batric Babovic, Srdjan Djuranovic, Olgica Mihaljevic, Katarina Sakic, Jelena Borovinic Bojovic, Irena Radoman Vujacic, Natasa Belada Babovic, Vladimir Jovanovic, Nebojsa Zdravkovic, Vasilije Boskovic, Danilo Radunovic, Vladimir Prelevic, Ivica Petrovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.